Dunkel, Ira J.
Memorial Sloan Kettering Cancer Center
2 papers on CoChatORCID 0000-0001-8091-6067
Most cited papers
- Verified
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
Geoerger, B., Bergeron, C., Gore, L., Sender, L., Dunkel, I. J., Herzog, C., Brochez, L., Cruz, O., Nysom, K., Berghorn, E., et al. (2017) · European Journal of Cancer
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 98
- Verified
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: safety, efficacy, biomarker, and pharmacokinetics – CheckMate 908
Dunkel, I. J., Doz, F., Foreman, N. K., Hargrave, D., Lassaletta, A., André, N., Hansford, J. R., Hassall, T., Eyrich, M., Gururangan, S., et al. (2023) · Neuro-Oncology
Glioma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 73
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free